Found 8 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is R and Author is Rankin, M  [Clear All Filters]
2004
M. Speer, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, Results from the 2002-03 Palivizumab Outcomes Registry: focus on congenital airway abnormalities & neuromuscular disease, 2004.
M. Speer, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, Results from the 2002-03 Palivizumab Outcomes Registry: focus on congenital airway abnormalities & neuromuscular disease, 2004.
M. Speer, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, Results from the 2002-03 Palivizumab Outcomes Registry: focus on congenital airway abnormalities & neuromuscular disease. 2004 Pediatric Academic Societies Meeting, Pediatric Research, vol. 55, p. 237A-238A, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, T. Synagis®, RSV prophylaxis in 60 children with cystic fibrosis; results from the “Real World” experience - Palivizumab Outcomes Registry, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, Am J Resp Crit Care Med, vol. 169, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, 2004.
J. Romero, Cohen, A., Boron, M., and Rankin, M., RSV Prophylaxis in Minority Populations; Results from the Palivizumab Outcomes Registry 2002-2003, Pediatric Research, vol. 55, p. 237A, 2004.